Article
Screening and selection strategy for the establishment of biosimilar to trastuzumab-expressing CHO-K1 cell lines
2 Jan 2021
Abstract excerpt
Abstract The high prices of biopharmaceuticals or biologics used in the treatment of many diseases limit the access of patients to these novel therapies. One example is the monoclonal antibody trastuzumab, successfully used for breast cancer treatment. An economic alternative is the generation of biosimilars to these expensive biopharmaceuticals. Since antibody therapies may require large doses over a long period...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.